Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, CorMedix Inc (NASDAQ: CRMD) closed at $9.68 down -0.41% from its previous closing price of $9.72. In other words, the price has decreased by -$0.41 from its previous closing price. On the day, 2.52 million shares were traded. CRMD stock price reached its highest trading level at $9.7995 during the session, while it also had its lowest trading level at $9.4501.
Ratios:
For a deeper understanding of CorMedix Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 14 ’25 when Dillione Janet sold 30,000 shares for $11.42 per share. The transaction valued at 342,600 led to the insider holds 48,473 shares of the business.
Dillione Janet bought 30,000 shares of CRMD for $328,200 on Nov 14 ’25. On Nov 10 ’25, another insider, Erin Mistry, who serves as the Former Officer of the company, bought 13,543 shares for $10.98 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 762678016 and an Enterprise Value of 855882048. As of this moment, CorMedix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.71, and their Forward P/E ratio for the next fiscal year is 3.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.56 while its Price-to-Book (P/B) ratio in mrq is 2.03. Its current Enterprise Value per Revenue stands at 3.994 whereas that against EBITDA is 7.91.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.35, which has changed by -0.02713567 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $17.43, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -12.67%, while the 200-Day Moving Average is calculated to be -13.24%.
Shares Statistics:
For the past three months, CRMD has traded an average of 3.35M shares per day and 3910810 over the past ten days. A total of 78.35M shares are outstanding, with a floating share count of 69.35M. Insiders hold about 8.09% of the company’s shares, while institutions hold 50.85% stake in the company. Shares short for CRMD as of 1761868800 were 16599216 with a Short Ratio of 4.95, compared to 1759190400 on 15564623. Therefore, it implies a Short% of Shares Outstanding of 16599216 and a Short% of Float of 21.39.
